Atlas Trials

Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease

Clinical trial NCT00932646 · COMPLETED

Trial details

NCT number
NCT00932646
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2009-06-01
Primary completion
2010-05-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.